Endocrinology Archives

Videos

Semaglutide for T2D and CKD: Clinical application and navigating the PBS

In this Quick Case, Endocrinologist Dr Ramy Bishay reviews the evidence for semaglutide in type 2 diabetes and CKD, outlines its relevance and impact on glycaemic, renal and cardiovascular outcomes based on clinical trial evidence, and explains how to navigate PBS access and prescribing requirements (7 mins).

Videos

New maintenance dose of semaglutide: achieving greater weight loss outcomes in adults living with obesity

In this Quick Case, GP Dr Rob Hungerford presents a woman with obesity who has achieved significant weight loss on semaglutide but remains above her treatment goals. The case explores the STEP UP trial data and the potential benefits of dose escalation to support further weight loss and personalised obesity management (6 mins).

Podcasts

Vitamin D in Australian practice: Sun, supplements, and the evidence GP’s need

Professor Rachel Neale explores the complexities of vitamin D deficiency, sun exposure, testing and supplementation, offering practical insights beyond standard guidelines.

Podcasts

MHT: Initiation, safety, endometriosis & practical prescribing — Your questions answered

Practical, evidence-based answers on MHT prescribing and safety.

Clinical Articles

Personalising obesity pharmacotherapy through dose escalation: Insights from the STEP UP trial

How increasing GLP-1 dose can improve weight loss and health outcomes without risking safety..

Podcasts

Managing obesity: Integrating GLP‑1 therapy with bariatric surgery

Dr Jason Winnett shares how GLP‑1 therapies have transformed his practice and how he integrates them with surgery, dietetics, psychology and exercise physiology in a truly holistic model of obesity care.

Podcasts

The peptide craze – What you need to know

Professor Gary Wittert answers questions about the peptide craze and addresses the issue from the clinician's perspective.

Podcasts

The impact of PFAS & other endocrine disrupting chemicals on fertility

Dr Terri Foran discusses the major concerns associated with ubiquitous compounds that include dioxins, BPAs and phthalates.

Podcasts

OCP, contraception and menopause – Your questions answered

A/Prof Gino Pecoraro OAM discusses how to choose and review hormonal contraception and menopausal hormone therapy across different life stages.

Podcasts

Navigating perimenopause and menopause – Managing weight, health and wellbeing

Dr Georgia Rigas and Dr Nadia Tejani joins Dr Angela Kwong to unpack perimenopausal weight gain, cardiometabolic risk, and the evolving roles of MHT and GLP‑1s in midlife care.

Podcasts

Adjuvant hormone therapy in breast cancer

Dr Susannah Graham and Dr Sanjeev Kumar unpack the practicalities of adjuvant endocrine therapy after breast cancer, from drug choice and duration to balancing benefit against toxicity.

Videos

Clinical case: Tirzepatide dose reduction and the impact on long-term maintenance of weight loss

In this Quick Case, Endocrinologist A/Prof Samantha Hocking outlines evidence from the SURMOUNT-MAINTAIN study, demonstrating how tirzepatide dose reduction or elimination impacts the maintenance of weight loss, cardiometabolic benefits, and clinical decision-making in obesity management (5 mins).

Endocrinology

Semaglutide for T2D and CKD: Clinical application and navigating the PBS

New maintenance dose of semaglutide: achieving greater weight loss outcomes in adults living with obesity

Vitamin D in Australian practice: Sun, supplements, and the evidence GP’s need

Professor Rachel Neale explores the complexities of vitamin D deficiency, sun exposure, testing and supplementation, offering practical insights beyond standard guidelines.

MHT: Initiation, safety, endometriosis & practical prescribing — Your questions answered

Practical, evidence-based answers on MHT prescribing and safety.

Personalising obesity pharmacotherapy through dose escalation: Insights from the STEP UP trial

How increasing GLP-1 dose can improve weight loss and health outcomes without risking safety..

Managing obesity: Integrating GLP‑1 therapy with bariatric surgery

Dr Jason Winnett shares how GLP‑1 therapies have transformed his practice and how he integrates them with surgery, dietetics, psychology and exercise physiology in a truly holistic model of obesity care.

The peptide craze – What you need to know

Professor Gary Wittert answers questions about the peptide craze and addresses the issue from the clinician's perspective.

The impact of PFAS & other endocrine disrupting chemicals on fertility

Dr Terri Foran discusses the major concerns associated with ubiquitous compounds that include dioxins, BPAs and phthalates.

OCP, contraception and menopause – Your questions answered

A/Prof Gino Pecoraro OAM discusses how to choose and review hormonal contraception and menopausal hormone therapy across different life stages.

Navigating perimenopause and menopause – Managing weight, health and wellbeing

Dr Georgia Rigas and Dr Nadia Tejani joins Dr Angela Kwong to unpack perimenopausal weight gain, cardiometabolic risk, and the evolving roles of MHT and GLP‑1s in midlife care.

Adjuvant hormone therapy in breast cancer

Dr Susannah Graham and Dr Sanjeev Kumar unpack the practicalities of adjuvant endocrine therapy after breast cancer, from drug choice and duration to balancing benefit against toxicity.

Clinical case: Tirzepatide dose reduction and the impact on long-term maintenance of weight loss

In this Quick Case, Endocrinologist A/Prof Samantha Hocking outlines evidence from the SURMOUNT-MAINTAIN study, demonstrating how tirzepatide dose reduction or elimination impacts the maintenance of weight loss, cardiometabolic benefits, and clinical decision-making in obesity management (5 mins).

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Endocrinology

Professor Rachel Neale explores the complexities of vitamin D deficiency, sun exposure, testing and supplementation, offering practical insights beyond standard guidelines.

Practical, evidence-based answers on MHT prescribing and safety.

How increasing GLP-1 dose can improve weight loss and health outcomes without risking safety..

Dr Jason Winnett shares how GLP‑1 therapies have transformed his practice and how he integrates them with surgery, dietetics, psychology and exercise physiology in a truly holistic model of obesity care.

Professor Gary Wittert answers questions about the peptide craze and addresses the issue from the clinician's perspective.

Dr Terri Foran discusses the major concerns associated with ubiquitous compounds that include dioxins, BPAs and phthalates.

A/Prof Gino Pecoraro OAM discusses how to choose and review hormonal contraception and menopausal hormone therapy across different life stages.

Dr Georgia Rigas and Dr Nadia Tejani joins Dr Angela Kwong to unpack perimenopausal weight gain, cardiometabolic risk, and the evolving roles of MHT and GLP‑1s in midlife care.

Dr Susannah Graham and Dr Sanjeev Kumar unpack the practicalities of adjuvant endocrine therapy after breast cancer, from drug choice and duration to balancing benefit against toxicity.

In this Quick Case, Endocrinologist A/Prof Samantha Hocking outlines evidence from the SURMOUNT-MAINTAIN study, demonstrating how tirzepatide dose reduction or elimination impacts the maintenance of weight loss, cardiometabolic benefits, and clinical decision-making in obesity management (5 mins).

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.